Novelty processing and memory formation in Parkinson's disease

Neuropsychologia

Volumn 62, Issue 1, 2014, Pages 124-136

  Schomaker, J ^a   Berendse, H W ^b   Foncke, E M J ^b   van der Werf, Y D ^b,c   van den Heuvel, O A ^b   Theeuwes, J ^a   Meeter, M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Dopamine; Learning; Memory; Novelty processing; Parkinson's disease; Von Restorff effect

Indexed keywords

AMANTADINE; BENSERAZIDE PLUS LEVODOPA; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; PROPRANOLOL; RASAGILINE; ROPINIROLE;

ADULT; AGED; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; FEMALE; HUMAN; LEARNING; MALE; MEMORY; MENTAL FUNCTION; NOVELTY PROCESSING; PARKINSON DISEASE; RECALL; ANALYSIS OF VARIANCE; AUDITORY STIMULATION; BRAIN MAPPING; CASE CONTROL STUDY; COMPLICATION; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; LINGUISTICS; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY;

ACOUSTIC STIMULATION; AGED; ANALYSIS OF VARIANCE; BRAIN MAPPING; CASE-CONTROL STUDIES; DOPAMINE AGENTS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; VERBAL LEARNING; VOCABULARY;

EID: 84905438914     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2014.07.016     Document Type: Article

References (132)

1. Aggleton J.P., Brown M.W. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behavioral and Brain Sciences 1999, 22:425-489.
2. Agid Y., Ruberg M., Javoy-Agid F., Hirsch E., Raisman-Vozari R., Vyas S., et al. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?. Advances in Neurology 1993, 60:148-164.
3. Albrecht M.A., Martin-Iverson M.T., Price G., Lee J., Iyyalol R. Dexamphetamine-induced reduction of P3a and P3b in healthy participants. Journal of Psychopharmacology 2011, 25(12):1623-1631. 10.1177/0269881110376686.
4. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 1986, 9:357-381. 10.1146/annurev.ne.09.030186.002041.
5. Antal A., Keri S., Kincses Z.T., Dibo G., Szabo A., Benedek G., et al. Dopaminergic contributions to the visual categorization of natural scenes: evidence from Parkinson's disease. Journal of Neural Transmission 2003, 110(7):757-770. 10.1007/s00702-003-0833-9.
6. Aragane K., Tachibana H., Sugita M. [Visual event-related potentials and reaction time in Parkinson's disease]. Nihon Ronen Igakkai Zasshi 1995, 32(10):628-636.
7. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting & Clinical Psychology 1988, 56(6):893-897.
8. Bell A J, Sejnowski T J An information maximisation approach to blind separation and blind deconvolution. Neural Computation 1995, 7(6):1129-1159.
9. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4:561-571.
10. Benchenane K., Peyrache A., Khamassi M., Tierney P.L., Gioanni Y., Battaglia F.P., et al. Coherent theta oscillations and reorganization of spike timing in the hippocampal- prefrontal network upon learning. Neuron 2010, 66(6):921-936. (doi: S0896-6273(10)00381-8 [pii] 0.1016/j.neuron.2010.05.013).
11. Betchen S.A., Kaplitt M. Future and current surgical therapies in Parkinson's disease. Current Opinion in Neurology 2003, 16(4):487-493. 10.1097/01.wco.0000084227.82329.ae.
12. Blum S., Hebert A.E., Dash P.K. A role for the prefrontal cortex in recall of recent and remote memories. NeuroReport 2006, 17(3):341-344. 10.1097/01.wnr.0000201509.53750.bc.
13. Bodis-Wollner I. Cognitive neurophysiology of Parkinson disease. Clinical EEG and Neuroscience 2010, 41(2). (VI).
14. Bodis-Wollner I. Current aspects of cognitive neurophysiology of Parkinson disease: an introduction. Clinical EEG and Neuroscience 2010, 41(2):68-75.
15. Borbely E., Scheich B., Helyes Z. Neuropeptides in learning and memory. Neuropeptides 2013, 47(6):439-450. 10.1016/j.npep.2013.10.012.
16. Bosboom J.L., Stoffers D., Wolters E.C. Cognitive dysfunction and dementia in Parkinson's disease. Journal of Neural Transmission 2004, 1303-1315.
17. Brown R.G., Marsden C.D. Cognitive function in Parkinson's disease: from description to theory. Trends in Neuroscience 1990, 13(1):21-29. (doi: 0166-2236(90)90058-I [pii]).
18. Bruce D., Gaines M.T. Tests of an organizational hypothesis of isolation effects in free-recall. Journal of Verbal Learning and Verbal Behavior 1976, 15(1):59-72. 10.1016/S0022-5371(76)90007-4.
19. Bunzeck N., Guitart-Masip M., Dolan R.J., Duzel E. Contextual novelty modulates the neural dynamics of reward anticipation. Journal of Neuroscience 2011, 31(36):12816-12822. 10.1523/JNEUROSCI.0461-11.2011.
20. Buytenhuijs E.L., Berger H.J., Van Spaendonck K.P., Horstink M.W., Borm G.F., Cools A.R. Memory and learning strategies in patients with Parkinson's disease. Neuropsychologia 1994, 32(3):335-342. (doi: 0028-3932(94)90135-X [pii]).
21. Chao O.Y., Pum M.E., Huston J.P. The interaction between the dopaminergic forebrain projections and the medial prefrontal cortex is critical for memory of objects: implications for Parkinson[U+05F3]s disease. Experimental Neurology 2013, 247:378-382.
22. Chiodo L.A., Antelman S.M., Caggiula A.R., Lineberry C.G. Sensory stimuli alter the discharge rate of dopamine (Da) neurons - evidence for 2 functional types of Da-cells in the substantia nigra. Brain Research 1980, 189(2):544-549. 10.1016/0006-8993(80)90366-2.
23. Contreras-Vidal JosŽ, Schultz Wolfram. A predictive reinforcement model of dopamine neurons for learning approach behavior. Journal of Computational Neuroscience 1999, 6:191-214.
24. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cerebral Cortex 2001, 11(12):1136-1143.
25. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Mechanisms of cognitive set flexibility in Parkinson's disease. Brain 2001, 124(Pt 12):2503-2512.
26. Courchesne E., Hillyard S.A., Galambos R. Stimulus novelty, task relevance and the visual evoked potential in man. Electroencephalography and Clinical Neurophysiology 1975, 39(2):131-143.
27. Dagher A. Functional imaging in Parkinson[U+05F3]s disease. Seminars in Neurology 2001, 21(1):23-32.
28. Delis D.C., Kramer J.H., Kaplan E., Holdnack J. Reliability and validity of the Delis-Kaplanexecutive function system: an update. The Journal of the International Neuropsychological Society 2004, 10(2):301-303. ([pii]). 10.1017/S1355617704102191S1355617704102191.
29. Delis D.C., Kaplan E., Kramer J.H. Delis-Kaplan Executive Function System (D-KEFS) 2001, The Psychological Corporation, San Antonio, TX.
30. Dias R., Robbins T.W., Roberts A.C. Dissociation in prefrontal cortex of affective and attentional shifts. Nature 1996, 380(6569):69-72. 10.1038/380069a0.
31. Delorme A., Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. Journal of Neuroscience Methods 2005, 134(1):9-21.
32. Djaldetti R., Lorberboym M., Karmon Y., Treves T.A., Ziv I., Melamed E. Residual striatal dopaminergic nerve terminals in very long-standing Parkinson's disease: a single photon emission computed tomography imaging study. Movement Disorders 2011, 26(2):327-330. 10.1002/Mds.23380.
33. Dunlosky J., Hunt R.R., Clark E. Is perceptual salience needed in explanations of the isolation effect?. Journal of Experimental Psychology Learning Memory and Cognition 2000, 26(3):649-657.
34. Dunn B.R., Dunn D.A., Languis M., Andrews D. The relation of ERP components to complex memory processing. Brain and Cognition 1998, 36(3):355-376. (doi: S0278-2626(98)90998-8 [pii] 0.1006/brcg.1998.0998).
35. Edelstyn N.M., Mayes A.R., Denby C., Ellis S.J. Impairment in material-specific long-term memory following unilateral mediodorsal thalamic damage and presumed partial disconnection of the mammillo-thalamic tract. Journal of Neuropsychology 2012, 6(1):119-140. 10.1111/j.1748-6653.2011.02019.x.
36. Edelstyn N.M., Shepherd T.A., Mayes A.R., Sherman S.M., Ellis S.J. Effect of disease severity and dopaminergic medication on recollection and familiarity in patients with idiopathic nondementing Parkinson's. Neuropsychologia 2010, 48(5):1367-1375. (doi: S0028-3932(09)00525-9 [pii] 0.1016/j.neuropsychologia.2009.12.039).
37. Fabiani M., Donchin E. Encoding processes and memory organization: a model of the von Restorff effect. Journal of Experimental Psychology Learning Memory and Cognition 1995, 21(1):224-240.
38. Fabiani M., Karis D., Donchin E. Effects of mnemonic strategy manipulation in a Von Restorff paradigm. Electroencephalography and Clinical Neurophysiology 1990, 75(2):22-35.
39. Fearnley J.M., Lees A.J. Aging and Parkinsons-disease - substantia-nigra regional selectivity. Brain 1991, 114:2283-2301. 10.1093/brain/114.5.2283.
40. Fischer P., Gatterer G., Simanyi M., Jellinger K., Marterer A., Danielczyk K., et al. Memory deficits in advanced Parkinson's disease. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 1990, 2(1):59-70.
41. Floel A., Garraux G., Xu B., Breitenstein C., Knecht S., Herscovitch P., et al. Levodopa increases memory encoding and dopamine release in the striatum in the elderly. Neurobiology of Aging 2008, 29(2):267-279. (doi: S0197-4580(06)00382-4 [pii] 0.1016/j.neurobiolaging.2006.10.009).
42. Floresco S.B., Grace A.A. Gating of hippocampal-evoked activity in prefrontal cortical neurons by inputs from the mediodorsal thalamus and ventral tegmental area. Journal of Neuroscience 2003, 23(9):3930-3943. (doi: 23/9/3930 [pii]).
43. Flowers K.A., Pearce I., Pearce J.M. Recognition memory in Parkinson's disease. The Journal of Neurology, Neurosurgery, and Psychiatry 1984, 47(11):1174-1181.
44. Freunberger R., Klimesch W., Doppelmayr M., Holler Y. Visual P2 component is related to theta phase-locking. Neuroscience Letters 2007, 426(3):181-186. (doi: S0304-3940(07)00948-2 [pii] 0.1016/j.neulet.2007.08.062).
45. Friedman D., Cycowicz Y.M., Gaeta H. The novelty P3: an event-related brain potential (ERP) sign of the brain's evaluation of novelty. Neuroscience & Biobehavioral Reviews 2001, 25(4):355-373. (doi: S0149-7634(01)00019-7 [pii]).
46. Gaeta H., Friedman D., Hunt G. Stimulus characteristics and task category dissociate the anterior and posterior aspects of the novelty P3. Psychophysiology 2003, 40(2):198-208.
47. Geraci L., Manzano I. Distinctive items are salient during encoding: delayed judgements of learning predict the isolation effect. Quarterly Journal of Experimental Psychology 2010, 63(1):50-64. (doi: 910486778 [pii]10.1080/17470210902790161).
48. Geraci L., Rajaram S. The distinctiveness effect in the absence of conscious recollection: evidence from conceptual priming. Journal of Memory and Language 2004, 51e(2):217-230. 10.1016/j.jml.2004.04.002.
49. Gibb W.R., Luthert P.J., Janota I., Lantos P.L. Cortical Lewy body dementia: clinical features and classification. Journal of Neurology, Neurosurgery, and Psychiatry 1989, 52(2):185-192.
50. Gotham A.M., Brown R.G., Marsden C.D. [U+05F3]Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 1988, 111(Pt 2):299-321.
51. Green J., Woodard J.L., Sirockman B.E., Zakers G.O., Maier C.L., Green R.C., et al. Event-related potential P3 change in mild Parkinson's disease. Movement Disorders 1996, 11(1):32-42. 10.1002/mds.870110108.
52. Halliday R., Naylor H., Brandeis D., Callaway E., Yano L., Herzig K. The effect of D-amphetamine, clonidine, and yohimbine on human information processing. Psychophysiology 1994, 31(4):331-337.
53. Hammerer D., Biele G., Muller V., Thiele H., Nurnberg P., Heekeren H.R., et al. Effects of PPP1R1B (DARPP-32) polymorphism on feedback-related brain potentials across the life span. Frontiers in Psychology 2013, 4(89). 10.3389/fpsyg.2013.00089.
54. Heitland I., Kenemans J.L., Oosting R.S., Baas J.M., Bocker K.B. Auditory event-related potentials (P3a, P3b) and genetic variants within the dopamine and serotonin system in healthy females. Behavioural Brain Research 2013, 249:55-64. 10.1016/j.bbr.2013.04.013.
55. Helkala E.L., Laulumaa V., Soininen H., Riekkinen P.J. Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases. Annals of Neurology 1988, 24(2):214-217. 10.1002/ana.410240207.
56. Hoehn M., Yahr M. Parkinsonism: Onset, progression and mortality. Neurology 1967, 17:427-442.
57. Horvitz J.C. Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 2000, 96(4):651-656. (doi: S0306452200000191 [pii]).
58. Horvitz J.C., Stewart T., Jacobs B.L. Burst activity of ventral tegmental dopamine neurons is elicited by sensory stimuli in the awake cat. Brain Research 1997, 759(2):251-258. (doi: S0006-8993(97)00265-5 [pii]).
59. Houk J.C. Agents of the mind. Biological Cybernetics 2005, 92(6):427-437. 10.1007/s00422-005-0569-8.
60. Humphries M.D., Prescott T.J. The ventral basal ganglia, a selection mechanism at the crossroads of space, strategy, and reward. Progress in Neurobiology 2010, 90(4):385-417. (doi: S0301-0082(09)00183-X [pii] 10.1016/j.pneurobio.2009.11.003).
61. Kamp S.M., Brumback T., Donchin E. The component structure of ERP subsequent memory effects in the Von Restorff paradigm and the word frequency effect in recall. Psychophysiology 2013, 50(11):1079-1093. 10.1111/psyp.12090.
62. Kaplan Goodglass, Harold Weintraub, Sandra Boston Naming Test 1983, Lea & Febiger, Philadelphia.
63. Karis D., Fabiani M., Donchin E. P300 and Memory - individual-differences in the Vonrestorff Effect. Cognitive Psychology 1984, 16(2):177-216.
64. Kazmerski V.A., Friedman D. Repetition of novel stimuli in an ERP oddball paradigm: aging effects. Journal of Psychophysiology 1995, 9(4):298-311.
65. Kehagia A.A., Barker R.A., Robbins T.W. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurology 2010, 9(12):1200-1213. 10.1016/S1474-4422(10)70212-X.
66. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. New England Journal of Medicine 1988, 318(14):876-880. 10.1056/NEJM198804073181402.
67. Knecht Stefan, Breitenstein Caterina, Bushuven Stefan, Wailke Stefanie, Kamping Sandra, Floel Agnes, et al. Levodopa: faster and better word learning in normal humans. Annals of neurology 2004, 56(1):20-26.
68. Lewis S.J., Dove A., Robbins T.W., Barker R.A., Owen A.M. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. Journal of Neuroscience 2003, 23(15):6351-6356. (doi: 23/15/6351 [pii]).
69. Lisman J.E., Grace A.A. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 2005, 46(5):703-713.
70. Ljungberg T., Apicella P., Schultz W. Responses of monkey dopamine neurons during learning of behavioral reactions. Journal of Neurophysiology 1992, 67(1):145-163.
71. Ljungberg Tomas, Apicella Paul, Schultz Wolfram. Responses of monkey midbrain dopamine neurons during delayed alternation performance. Brain Research 1991, 567:337-341.
72. Luck S.J. An introduction to the event-related potential technique 2005, MIT, Cambridge, MA; London.
73. Macdonald P.A., Monchi O. Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function. Parkinson's Disease 2011, 2011:572743. 10.4061/2011/572743.
74. Mathis S., Neau J.P., Pluchon C., Fargeau M.N., Karolewicz S., Iljicsov A., et al. Apathy in Parkinson's disease: an electrophysiological study. Neurology Research International 2014, 2014:290513. 10.1155/2014/290513.
75. McDaniel M.A., Dornburg C.C., Guynn M.J. Disentangling encoding versus retrieval explanations of the bizarreness effect: implications for distinctiveness. Memory & Cognition 2005, 33(2):270-279.
76. Mehta M.A., Swainson R., Ogilvie A.D., Sahakian B.J., Robbins T.W. Improved short-term spatial memory but impaired following the dopamine D-2 agonist bromocriptine reversal learning in human volunteers. Psychopharmacology 2001, 159(1):10-20.
77. Mohr E., Fabbrini G., Williams J., Schlegel J., Cox C., Fedio P., et al. Dopamine and memory function in Parkinson's disease. Movement Disorders 1989, 4(2):113-120. 10.1002/mds.870040202.
78. Narayanan N.S., Rodnitzky R.L., Uc E.Y. Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease. Reviews in the Neurosciences 2013, 24(3):267-278. 10.1515/revneuro-2013-0004.
79. Nelson H.E. National Adult Reading Test (NART): For the Assessment of Premorbid Intelligence in Patients with Dementia: Test Manual 1982, NFER-Nelson, Windsor, UK.
80. Nishimura N., Ogura C., Ohta I. Effects of the dopamine-related drug bromocriptine on event-related potentials and its relation to the law of initial value. Psychiatry and Clinical Neuroscience 1995, 49(1):79-86.
81. Olde Dubbelink K.T., Stoffers D., Deijen J.B., Twisk J.W., Stam C.J., Berendse H.W. Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study. Neurobiology of Aging 2013, 34(2):408-418. 10.1016/j.neurobiolaging.2012.02.029.
82. Oranje B., Gispen-de Wied C.C., Westenberg H.G., Kemner C., Verbaten M.N., Kahn R.S. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention. The Journal of Psychopharmacology 2006, 20(6):789-798. 10.1177/0269881106061712.
83. Otten L.J., Donchin E. Relationship between P300 amplitude and subsequent recall for distinctive events: dependence on type of distinctiveness attribute. Psychophysiology 2000, 37(5):644-661.
84. Owen A.M., Doyon J., Dagher A., Sadikot A., Evans A.C. Abnormal basal ganglia outflow in Parkinson[U+05F3]s disease identified with PET. Implications for higher cortical functions. Brain 1998, 121(5):949-965.
85. Owen A.M. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist 2004, 10(6):525-537. (doi: 10/6/525 [pii]10.1177/1073858404266776).
86. Owen A.M., James M., Leigh P.N., Summers B.A., Marsden C.D., Quinn N.P., et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992, 115(Pt 6):1727-1751.
87. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt impulsiveness scale. Journal of Clinical Psychology 1995, 51(6):768-774.
88. Pergola G., Suchan B. Associative learning beyond the medial temporal lobe: many actors on the memory stage. Frontiers in Behavioral Neuroscience 2013, 7(162). 10.3389/fnbeh.2013.00162.
89. Polich J. Updating P300: an integrative theory of P3a and P3b. Clinical Neurophysiology 2007, 118(10):2128-2148. (doi: S1388-2457(07)00189-7 [pii] 10.1016/j.clinph.2007.04.019).
90. Polich J., Criado J.R. Neuropsychology and neuropharmacology of P3a and P3b. International Journal of Psychophysiology 2006, 60(2):172-185. (doi: S0167-8760(06)00021-3 [pii] 0.1016/j.ijpsycho.2005.12.012).
91. Pulvermuller F., Lutzenberger W., Muller V., Mohr B., Dichgans J., Birbaumer N. P3 and contingent negative variation in Parkinson's disease. Electroencephalography and Clinical Neurophysiology 1996, 98(6):456-467.
92. Ramaker C., Marinus J., Stiggelbout A.M., Van Hilten B.J. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Movement Disorders 2002, 17(5):867-876. 10.1002/mds.10248.
93. Ranganath C., Rainer G. Neural mechanisms for detecting and remembering novel events. Nature Reviews Neuroscience 2003, 4(3):193-202. (nrn1052 [pii]). 10.1038/nrn1052.
94. Rangel-Gomez M., Hickey C., Meeter M. The detection of novelty relies on dopaminergic signaling:evidence from Apomorphine's impact on the novelty N2. Psychophysiology 2012, 49:S82. (-S82).
95. Rangel-Gomez M., Hickey C., van Amelsvoort T., Bet P., Meeter M. The detection of novelty relies on dopaminergic signaling: evidence from apomorphine's impact on the novelty N2. PLoS One 2013, 8(6):e66469. (PONE-D-13-12004 [pii]). 10.1371/journal.pone.0066469.
96. Rangel-Gomez M., Meeter M. Electrophysiological analysis of the role of novelty in the von Restorff effect. Brain and Behavior 2013, 3(2):159-170. 10.1002/brb3.112.
97. Righi S., Viggiano M.P., Paganini M., Ramat S., Marini P. Recognition of category-related visual stimuli in Parkinson's disease: before and after pharmacological treatment. Neuropsychologia 2007, 45(13):2931-2941. 10.1016/j.neuropsychologia.2007.06.002.
98. Riis J.L., Chong H., McGinnnis S., Tarbi E., Sun X., Holcomb P.J., et al. Age-related changes in early novelty processing as measured by ERPs. Biological Psychology 2009, 82(1):33-44. (doi: S0301-0511(09)00101-X [pii] 0.1016/j.biopsycho.2009.05.003).
99. Rosvold H.E. The frontal lobe system: cortical-subcortical interrelationships. Acta Neurobiologiae Experimentalis(Wars) 1972, 32(2):439-460.
100. Rushby J.A., Barry R.J., Johnstone S.S. Event-related potential correlates of serial-position effects during an elaborative memory test. International Journal of Psychophysiology 2002, 46(1):13-27. (doi: S0167876002000375 [pii]).
101. Ruzicka E., Roth J., Spackova N., Mecir P., Jech R. Apomorphine induced cognitive changes in Parkinson's disease. The Journal of Neurology, Neurosurgery, and Psychiatry 1994, 57(8):998-1001.
102. Sagar H.J., Sullivan E.V., Gabrieli J.D., Corkin S., Growdon J.H. Temporal ordering and short-term memory deficits in Parkinson's disease. Brain 1988, 111(Pt 3):525-539.
103. Sambeth A., Huotilainen M., Kushnerenko E., Fellman V., Pihko E. Newborns discriminate novel from harmonic sounds: a study using magnetoencephalography. Clinical Neurophysiology 2006, 117(3):496-503.
104. Sartucci F., Guerrini V., Tognoni G., Massetani R., Murri L., Muratorio A. [P300 and Parkinson disease. The role of cognitive changes]. RIvista Di Neurologia 1990, 60(6):229-233.
105. Sawamoto N., Piccini P., Hotton G., Pavese N., Thielemans K., Brooks D.J. Cognitive deficits and striato-frontal dopamine release in Parkinson[U+05F3]s disease. Brain 2008, 131(5):1294-1302.
106. Schmidt S.R. Encoding and retrieval-processes in the memory for conceptually distinctive events. Journal of Experimental Psychology-Learning Memory and Cognition 1985, 11(3):565-578. 10.1037/0278-7393.11.3.565.
107. Schmidt S.R. Can we have a distinctive theory of memory. Memory & Cognition 1991, 19(6):523-542. 10.3758/Bf03197149.
108. Schultz W. Predictive reward signal of dopamine neurons. Journal of Neurophysiology 1998, 80:1-27.
109. Schultz W., Dayan P., Montague P.R. A neural substrate of prediciton and reward. Science 1992, 275:1593-1599.
110. Simons R.F., Graham F.K., Miles M.A., Chen X. On the relationship of P3a and the Novelty-P3. Biological Psychology 2001, 56(3):207-218. (doi: S0301051101000783 [pii]).
111. Solis-Vivanco R., Ricardo-Garcell J., Rodriguez-Camacho M., Prado-Alcala R.A., Rodriguez U., Rodriguez-Violante M., et al. Involuntary attention impairment in early Parkinson's disease: an event-related potential study. Neuroscience Letters 2011, 495(2):144-149. 10.1016/j.neulet.2011.03.058.
112. Soltani M., Knight R.T. Neural origins of the P300. Critical Reviews in Neurobiology 2000, 14(3-4):199-224.
113. Spaan P.E.J. Early assessment of dementia: The contributuion of different memory components 2003, University of Amsterdam, the Netherlands.
114. Squires N.K., Squires K.C., Hillyard S.A. Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man. Electroencephalography and Clinical Neurophysiology 1975, 38(4):387-401.
115. Steinfels G.F., Heym J., Strecker R.E., Jacobs B.L. Response of dopaminergic neurons in cat to auditory stimuli presented across the sleep-waking cycle. Brain Research 1983, 277(1):150-154. (doi: 0006-8993(83)90917-4 [pii]).
116. Strecker R.E., Jacobs B.L. Substantia-Nigra dopaminergic unit-activity in behaving cats - effect of arousal onspontaneous discharge and sensory evoked activity. Brain Research 1985, 361(1-2):339-350. 10.1016/0006-8993(85)91304-6.
117. Sullivan E.V., Sagar H.J. Nonverbal recognition and recency discrimination deficits in Parkinson's disease and Alzheimer's disease. Brain 1989, 112(Pt 6):1503-1517.
118. Swainson R., Rogers R.D., Sahakian B.J., Summers B.A., Polkey C.E., Robbins T.W. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 2000, 38(5):596-612. 10.1016/S0028-3932(99)00103-7.
119. Swainson R., Rogers R., Sahakian B., Summers B., Polkey C., Robbins T. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 2000, 38:596-612.
120. Takeshita S., Ogura C. Effect of the dopamine D2 antagonist sulpiride on event-related potentials and its relation to the law of initial value. International Journal of Psychophysiology 1994, 16(1):99-106.
121. Tanaka H., Koenig T., Pascual-Marqui R.D., Hirata K., Kochi K., Lehmann D. Event-related potential and EEG measures in Parkinson's disease without and with dementia. Dementia and Geriatric Cognitive Disorders 2000, 11(1):39-45. (doi: 17212).
122. Taylor A.E., Saint-Cyr J.A., Lang A.E. Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain 1986, 109(Pt 5):845-883.
123. Toda K. [Cognitive processes in Parkinson's disease--an event-related potential analysis]. Nihon Ronen Igakkai Zasshi 1991, 28(6):801-810.
124. Tombaugh T.N. Trail making test A and B: normative data stratified by age and education. Archives of Clinical Neuropsychology 2004, 19(2):203-214. 10.1016/S0887-6177(03)00039-8.
125. Tweedy J.R., Langer K.G., McDowell F.H. The effect of semantic relations on the memory deficit associated with Parkinson's disease. Journal of Clinical Neuropsychology 1982, 4(3):235-247.
126. Verhage Revised scoring method for educational level 1983, University Hospital Groningen: Department of Neuropsychology.
127. Von Restorff H Über die Wirkung von Bereichsbildungen im Spurenfeld [The effects of field formation in the trace field]. Psychologie Forschung 1933, 18. (299-234).
128. Voorn P., Vanderschuren L.J., Groenewegen H.J., Robbins T.W., Pennartz C.M. Putting a spin on the dorsal-ventral divide of the striatum. Trends in Neuroscience 2004, 27(8):468-474. (S0166-2236(04)00190-0 [pii]). 10.1016/j.tins.2004.06.006.
129. Vriend C., Pattij T., van der Werf Y.D., Voorn P., Booij J., Rutten S., et al. Depression and impulse control disorders in Parkinson's disease: two sides of the same coin?. Neuroscience & Biobehavioral Reviews 2014, 38:60-71. 10.1016/j.neubiorev.2013.11.001.
130. Weingartner H., Burns S., Diebel R., LeWitt P.A. Cognitive impairments in Parkinson's disease: distinguishing between effort-demanding and automatic cognitive processes. Psychiatry Research 1984, 11(3):223-235. (doi: 0165-1781(84)90071-4 [pii]).
131. Wiswede D., Russeler J., Hasselbach S., Munte T.F. Memory recall in arousing situations - an emotional von Restorff effect?. BMC Neuroscience 2006, 7(57). (doi: 1471-2202-7-57 [pii] 10.1186/1471-2202-7-57).
132. Wright M.J., Geffen G.M., Geffen L.B. ERP measures of stimulus processing during an auditory oddball task in Parkinson's disease: Evidence for an early information processing deficit. Parkinsonism & Related Disorders 1996, 2(1):13-21.